All times are listed in CEST (Central European Summer Time)
Special session
Date
Mon, 12.09.2022
Time
10:15 - 11:45
Location
7.3.U - Urval Auditorium
Chairs
- Nicholas McGranahan (London, United Kingdom)
- Fabrice André (Villejuif, France)
Session Type
Special session
Special session
What defines “born to be bad” cancers?
Speakers
- Nicholas McGranahan (London, United Kingdom)
Lecture Time
10:15 - 10:35
Session Name
Location
7.3.U - Urval Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
10:15 - 11:45
Special session
Small cell lung cancer: How molecular insights have shed light on aggressive clinical behaviour
Speakers
- Charles M. Rudin (New York, United States of America)
Lecture Time
10:35 - 10:55
Session Name
Location
7.3.U - Urval Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
10:15 - 11:45
Special session
Dissecting response to treatment in adult patients with a glioma
Speakers
- Roel G. Verhaak (Farmington, United States of America)
Lecture Time
10:55 - 11:15
Session Name
Location
7.3.U - Urval Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
10:15 - 11:45
Special session
How can we accelerate drug discovery and development for patients with hard-to-treat cancers?
Speakers
- Elena Garralda (Barcelona, Spain)
Lecture Time
11:15 - 11:35
Session Name
Location
7.3.U - Urval Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
10:15 - 11:45
Special session
Discussion
Speakers
- All Speakers (Lugano, Switzerland)
Lecture Time
11:35 - 11:45
Session Name
Location
7.3.U - Urval Auditorium, Paris Expo Porte de Versailles, Paris, France
Date
Mon, 12.09.2022
Time
10:15 - 11:45